Lizzy Lawrence

The Trump administration is rolling out a program aimed at getting Medicare to match prices in other countries for certain high-cost drugs, such as cancer and autoimmune disorder medicines.

U.S. states’ methods for obtaining the drugs used in carrying out executions are shrouded in secrecy.

New medications are showing promise in going after a certain kind of hard-to-target protein in diseased cells.

Read this exciting story from The Wall Street Journal October 16, 2026 issue. After Lisa Moore’s cancer treatments stopped working, the 64-year-old enrolled in a study to try out a new type of drug, one that is programmed to go after disease in cells in a novel way.

Novel approaches go after 85% of disease drivers that researchers haven't been able to attack

Shares of Disc Medicine rose around 37% on Monday after it announced that its experimental pill succeeded in easing symptoms in people with a rare disease that makes sunlight painful. Patients with the disease, called erythropoietic protoporphyria, accumulate a compound in their blood that reacts t

Details from a closely guarded mRNA-based cancer vaccine study were shared on social media.

Moderna shares plunged after details from a closely guarded mRNA-based cancer-vaccine study were shared on social media, raising concerns that the treatment might not be as effective as initially hoped.

The company’s stock dropped after details of a study raised questions about how widely the treatment would be used.

To the scientific world, Moderna's cancer vaccine's results proved that a highly personalized, immune-targeting medication can work. To investors, it didn't work well enough.